Brought to you by 
Takeda to buy Millennium for $8.2bn in cash
Apr 2008
Executive Summary
Japan's largest drug company Takeda will pay $25 per share (a 59% premium) in an all-cash $8.2bn deal to buy public Big Biotech Millennium Pharmaceuticals.
Deal Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Includes Contract
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com